Can you provide the upcoming earnings date for ERNEXA THERAPEUTICS INC?
ERNEXA THERAPEUTICS INC (ERNA) will report earnings on 2026-05-05.
ERNEXA THERAPEUTICS INC (ERNA) Forecast, Price Target & Analyst Ratings
NASDAQ:ERNA • US1140823089
Current stock price
0.1525 USD
+0 (+3.32%)
At close:
0.1464 USD
-0.01 (-4%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ERNEXA THERAPEUTICS INC (ERNA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.15 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ERNA was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ERNA.
In the previous month the buy percentage consensus was at a similar level.
ERNA was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 5, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 68K | 582K 755.88% | N/A -100.00% | ||
| EBITDA YoY % growth | -27.07M 0.88% | -20.591M 23.93% | -17.111M 16.90% | N/A 45.92% | |
| EBIT YoY % growth | -27.23M 0.73% | -20.675M 24.07% | -17.25M 16.57% | N/A 45.98% | |
| Operating Margin | N/A | -30,404.41% | -2,963.92% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ERNEXA THERAPEUTICS INC / ERNA Forecast FAQ
Can you provide the consensus rating for ERNEXA THERAPEUTICS INC stock?
The consensus rating for ERNEXA THERAPEUTICS INC (ERNA) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.